America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Knowing when to sell index funds in a recession helps protect capital and rebalance for future growth. This intro offers timing considerations.
15,106 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
The Central Bureau of Investigation in Mumbai said it has arrested a suspect tied to a crypto fraud operation linked ...
Gas prices in Illinois have jumped, putting the state near the top of the nation’s most expensive lists. This guide e...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
A federal judge weighing future of East Potomac Park golf course is ruling on whether to preserve the public course o...
When a public figure speaks openly about mental health, families listen. This piece honors martin short’s daughter ka...
A 56-year-old investor with $3.2M saved confronts a healthcare-cost hurdle that could push retirement beyond mid-50s....
BitGo’s Q1 2026 earnings reveal more than headline numbers. This guide translates the transcript into actionable insi...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...
A pivotal Investor Day pushed Schwab stock higher on Friday as management raised guidance on revenue growth and net i...
Investors often wonder if the memory chip darling Micron is still worth buying after a big run. This guide breaks dow...
A quiet SEC filing reveals a larger stake in Par Pacific. Explore what forest avenue capital adds means for investors...